ERAS vs MANE: stock comparison and AI forecast
Erasca, Inc. (ERAS) and Veradermics, Inc (MANE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ERAS Erasca, Inc.
- Market Cap
- $5.12B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
MANE Veradermics, Inc
- Price
- $133.61 +16.4% · 6M
- Market Cap
- $5.58B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ERAS and MANE have similar market capitalizations ($5.12B and $5.58B).
- ERAS carries 0.20 times debt per unit of equity, against 0.01 times for MANE.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ERAS | MANE |
|---|---|---|
| Market Cap | $5.12B | $5.58B |
| P/B Ratio | 14.15x | 6.86x |
| EPS | $-0.46 | – |
| Book Value/Share | $1.03 | $19.47 |
| FCF/Share | $-0.28 | – |
Profitability & Margins
| Metric | ERAS | MANE |
|---|---|---|
| ROIC | -75.4% | – |
Financial Health
| Metric | ERAS | MANE |
|---|---|---|
| Current Ratio | 8.29x | 70.53x |
| D/E Ratio | 0.20x | 0.01x |
| Financial Leverage | 1.20x | 1.01x |
| Working Capital | $245M | $813M |
Cash Flow
| Metric | ERAS | MANE |
|---|---|---|
| Operating Cash Flow | -$98M | – |
| Free Cash Flow | -$98M | – |
| Capital Spending | -$60K | – |
Income Statement
| Metric | ERAS | MANE |
|---|---|---|
| Operating Income | -$303M | – |
| R&D Expense | $109M | – |
Dividend & Shareholder Information
| Metric | ERAS | MANE |
|---|---|---|
| Shares Outstanding | 350M | 42M |
ERAS vs MANE: stock comparison and AI forecast
Which is bigger, ERAS or MANE?
ERAS and MANE have similar market capitalizations ($5.12B and $5.58B).
Which one does Intratio's AI model rank higher, ERAS or MANE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.